(Q39248297)

English

Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 September 2017

Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml (English)

1 reference

Europe PubMed Central

10 September 2017

radiation therapy

0 references

author name string

Rei Umezawa

1

1 reference

Europe PubMed Central

10 September 2017

Hisanori Ariga

2

1 reference

Europe PubMed Central

10 September 2017

Yoshihiro Ogawa

3

1 reference

Europe PubMed Central

10 September 2017

Keiichi Jingu

4

1 reference

Europe PubMed Central

10 September 2017

Haruo Matsushita

5

1 reference

Europe PubMed Central

10 September 2017

Ken Takeda

6

1 reference

Europe PubMed Central

10 September 2017

Keisuke Fujimoto

7

1 reference

Europe PubMed Central

10 September 2017

Toru Sakayauchi

8

1 reference

Europe PubMed Central

10 September 2017

Toshiyuki Sugawara

9

1 reference

Europe PubMed Central

10 September 2017

Masaki Kubozono

10

1 reference

Europe PubMed Central

10 September 2017

Kakutaro Narazaki

11

1 reference

Europe PubMed Central

10 September 2017

Eiji Shimizu

12

1 reference

Europe PubMed Central

10 September 2017

Yoshihiro Takai

13

1 reference

Europe PubMed Central

10 September 2017

Shogo Yamada

14

1 reference

Europe PubMed Central

10 September 2017

publication date

5 November 2011

1 reference

Europe PubMed Central

10 September 2017

Radiation Oncology

1 reference

Europe PubMed Central

10 September 2017

6

1 reference

Europe PubMed Central

10 September 2017

150

1 reference

Europe PubMed Central

10 September 2017

copyright license

Creative Commons Attribution 2.0 Generic

5 November 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1186/1748-717x-6-150

0 references

Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

10 September 2017

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

10 September 2017

Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

10 September 2017

Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

10 September 2017

Radiotherapy after prostatectomy: is the evidence for dose escalation out there?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

10 September 2017

Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

10 September 2017

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

10 September 2017

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

10 September 2017

Prostate specific antigen doubling time calculation: not as easy as 1, 2, 4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

10 September 2017

Rising prostate-specific antigen after primary prostate cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

10 September 2017

Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

10 September 2017

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

10 September 2017

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

10 September 2017

Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

10 September 2017

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

10 September 2017

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

14 September 2017

Salvage radiotherapy for biochemical relapse after complete PSA response following radical prostatectomy: outcome and prognostic factors for patients who have never received hormonal therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

15 June 2018

Early salvage radiotherapy for patients with PSA relapse after radical prostatectomy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

21 August 2018

Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

21 August 2018

Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

21 August 2018

Comparison of adjuvant versus salvage radiotherapy policies for postprostatectomy radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

21 August 2018

Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220651

21 August 2018

Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22053922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage radiation therapy for prostate specific antigen progression following radical prostatectomy: 10-year outcome estimates

1 reference

https://pubmed.ncbi.nlm.nih.gov/22053922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage radiotherapy for biochemical recurrence after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22053922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system

1 reference

https://pubmed.ncbi.nlm.nih.gov/22053922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in

1 reference

https://pubmed.ncbi.nlm.nih.gov/22053922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22053922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22053922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22053922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved outcomes with higher doses for salvage radiotherapy after prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22053922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22053922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22053922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22053922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/22053922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22053922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22053922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fractionation and protraction for radiotherapy of prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22053922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1748-717X-6-150

1 reference

Europe PubMed Central

10 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

10 September 2017

1 reference

Europe PubMed Central

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39248297&oldid=1999434673"